C12N 15/8633
Avian poxviral vectors
Official title: {Avian poxviral vectors}
C12N15/8633 (Avian poxviral vectors) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 3
- Assignees
- 2
- Inventors
- 7
- Latest grant
- 10 Nov 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
By publication year.
Recent patents
- Avian oncolytic virus having modified sequences and uses thereof10 Nov 2020US 10,829,786 B2ARV Pharma Inc.
- Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom26 Jun 2018US 10,006,050 B2Merial Limited
- Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom14 Feb 2017US 9,567,606 B2Merial Limited
- Avian oncolytic virus having modified sequences and uses thereof18 Jun 2020US 2020/0190538 A1ARV Pharma Inc.
- Recombinant Poxviral Vectors Expressing both Rabies and OX40 Proteins, and Vaccines Made Therefrom18 May 2017US 2017/0137843 A1Merial Limited
- Recombinant Poxviral Vectors Expressing both Rabies and OX40 Proteins, and Vaccines Made Therefrom15 Aug 2013US 2013/0209511 A1Merial Limited
Most cited
By later US patents